3 studies found for:    20818862 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Alisertib;   Drug: Abiraterone acetate;   Drug: Prednisone
2 Recruiting Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Conditions: Liver Cell Caricinoma;   Liver Cancer;   Hepatocellular Carcinoma
Interventions: Drug: Tremelimumab;   Procedure: Trans-Arterial Cather Chemoembolization;   Procedure: Radiofrequency Ablation (RFA)
3 Completed
Has Results
Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: Sipuleucel-T;   Biological: APC-Placebo

Indicates status has not been verified in more than two years